TP53 and ovarian cancer (Q35078757)

6 August 2017

1 reference

title

TP53 and ovarian cancer (English)

1 reference

6 August 2017

1 reference

Monique Schuijer

1

1 reference

6 August 2017

Els M J J Berns

series ordinal

2

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

285-291

1 reference

Genetic epidemiology of epithelial ovarian cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

The UMD-p53 database: new mutations and analysis tools

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Ovarian cancer in infertility patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

https://api.crossref.org/works/10.1002%2FHUMU.10181

1 reference

7 January 2021

High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Unusual case of Smith-Lemli-Opitz syndrome "type II"

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 and HER-2/neu overexpression in ovarian borderline tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Incessant ovulation--a factor in ovarian neoplasia?

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Factors in the causation and incidence of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Pooled analysis of 3 european case-control studies of ovarian cancer: II. Age at menarche and at menopause

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Cancer-susceptibility genes. Gatekeepers and caretakers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 expression in ovarian borderline tumors and stage I carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 gene analysis of ovarian borderline tumors and stage I carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Pooled analysis of 3 european case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

BRCA1 regulates p53-dependent gene expression

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Allelic loss on chromosome 17 in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Endocrine Factors in Common Epithelial Ovarian Cancer*

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in Israel

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Complexity of surveillance for cancer risk associated with in-vitro fertilisation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Is TP53 dysfunction required for BRCA1-associated carcinogenesis?

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Genetic alterations in ovarian borderline tumours and ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

The genetic analysis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Whole chromosome 17 loss in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Risk of cancer after use of fertility drugs with in-vitro fertilisation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

p53 gene mutation in human borderline epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10181

7 January 2021

Identifiers

DOI

10.1002/HUMU.10181

1 reference

6 August 2017

1 reference